Literature DB >> 27591105

Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.

Emily A Voigt1, Inna G Ovsyannikova1, Iana H Haralambieva1, Richard B Kennedy1, Beth R Larrabee2, Daniel J Schaid2, Gregory A Poland3.   

Abstract

In addition to host genetic and environmental factors, variations in immune responses to vaccination are influenced by demographic variables, such as race and sex. The influence of genetic race and sex on measles vaccine responses is not well understood, yet important for the development of much-needed improved measles vaccines with lower failure rates. We assessed associations between genetically defined race and sex with measles humoral and cellular immunity after measles vaccination in three independent and geographically distinct cohorts totaling 2872 healthy racially diverse children, older adolescents, and young adults. We found no associations between biological sex and either humoral or cellular immunity to measles vaccine, and no correlation between humoral and cellular immunity in these study subjects. Genetically defined race was, however, significantly associated with both measles vaccine-induced humoral and cellular immune responses, with subjects genetically classified as having African-American ancestry demonstrating significantly higher antibody and cell-mediated immune responses relative to subjects of Caucasian ancestry. This information may be useful in designing novel measles vaccines that are optimally effective across human genetic backgrounds.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Continental population groups; Immunity, cellular; Immunity, humoral; Measles; Measles vaccine; Measles virus; Measles-mumps-rubella vaccine; Sex factors

Mesh:

Substances:

Year:  2016        PMID: 27591105      PMCID: PMC5278779          DOI: 10.1016/j.vaccine.2016.08.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  51 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Use of Edmonston attenuated measles strain. A summary of three years' experience.

Authors:  S L KATZ; J F ENDERS; A HOLLOWAY
Journal:  Am J Dis Child       Date:  1962-03

3.  The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

4.  Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

5.  Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-02-13       Impact factor: 2.850

6.  Genome-wide association study of antibody response to smallpox vaccine.

Authors:  Inna G Ovsyannikova; Richard B Kennedy; Megan O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-04-25       Impact factor: 3.641

7.  Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.

Authors:  Jennifer B Rosen; Jennifer S Rota; Carole J Hickman; Sun B Sowers; Sara Mercader; Paul A Rota; William J Bellini; Ada J Huang; Margaret K Doll; Jane R Zucker; Christopher M Zimmerman
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

8.  Gender effects on humoral immune responses to smallpox vaccine.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Margaret A K Ryan; Gregory A Poland
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

9.  Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

10.  Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.

Authors:  S Kumakura; H Shibata; K Onoda; N Nishimura; C Matsuda; M Hirose
Journal:  Epidemiol Infect       Date:  2013-04-11       Impact factor: 2.451

View more
  13 in total

1.  Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4+ T cells to HIV infection.

Authors:  Carley Tasker; Amy Davidow; Natalie E Roche; Theresa L Chang
Journal:  Immunohorizons       Date:  2017-11-01

2.  Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

Authors:  Glenda E Gray; Ying Huang; Nicole Grunenberg; Fatima Laher; Surita Roux; Erica Andersen-Nissen; Stephen C De Rosa; Britta Flach; April K Randhawa; Ryan Jensen; Edith M Swann; Linda-Gail Bekker; Craig Innes; Erica Lazarus; Lynn Morris; Nonhlanhla N Mkhize; Guido Ferrari; David C Montefiori; Xiaoying Shen; Sheetal Sawant; Nicole Yates; John Hural; Abby Isaacs; Sanjay Phogat; Carlos A DiazGranados; Carter Lee; Faruk Sinangil; Nelson L Michael; Merlin L Robb; James G Kublin; Peter B Gilbert; M Juliana McElrath; Georgia D Tomaras; Lawrence Corey
Journal:  Sci Transl Med       Date:  2019-09-18       Impact factor: 17.956

3.  Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.

Authors:  Marguerite M Riggenbach; Iana H Haralambieva; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland; Richard B Kennedy
Journal:  Clin Immunol       Date:  2021-12-28       Impact factor: 3.969

4.  Proteomic assessment of humoral immune responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Diane E Grill; Gregory A Poland
Journal:  Vaccine       Date:  2021-12-21       Impact factor: 3.641

5.  Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.

Authors:  Inna G Ovsyannikova; Beth R Larrabee; Daniel J Schaid; Gregory A Poland
Journal:  Vaccine       Date:  2017-03-06       Impact factor: 4.169

Review 6.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

7.  Comparison of the immunogenicity and safety of 3 inactivated hepatitis A vaccines in Korean children aged 12 to 18 months: An open-label, randomized, prospective, multicenter study.

Authors:  Seung Soo Hong; Ui Yoon Choi; Sang Hyuk Ma; Soo Young Lee; Seung Beom Han; Kyung-Hyo Kim; Jin Han Kang; Jong-Hyun Kim
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

8.  Measles-Related Hospitalizations in Italy, 2004-2016: The Importance of High Vaccination Coverage.

Authors:  Fabiana Fiasca; Stefano Necozione; Leila Fabiani; Marianna Mastrodomenico; Antonella Mattei
Journal:  Ann Glob Health       Date:  2019-03-19       Impact factor: 2.462

9.  Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Whitney L Simon; Krista M Goergen; Diane E Grill; Inna G Ovsyannikova; Gregory A Poland
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.752

10.  Case report: Ribavirin and vitamin A in a severe case of measles.

Authors:  Amandine Bichon; Camille Aubry; Lucas Benarous; Hortense Drouet; Christine Zandotti; Philippe Parola; Jean-Christophe Lagier
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.